Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia

Journal of Clinical Endocrinology and Metabolism

Volumn 75, Issue 1, 1992, Pages 145-150

  Quarles, L Darryl ^a   Lobaugh, Bruce ^a   Murphy, Gayle ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BONE DISEASE; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; IMMUNORADIOMETRIC ASSAY; KIDNEY DISEASE; MALE; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; UREMIA;

ADULT; AGED; BONE AND BONES; BONE RESORPTION; FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; PARATHYROID HORMONES; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SUPPORT, U.S. GOV'T, P.H.S.; UREMIA;

EID: 0026652885     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.75.1.1619003     Document Type: Article

References (25)

1. Nussbaum SR, Zahradnik RJ, Lavigne J, et al. 1987 Highly sensitive two-site immunoradiometric assay for parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 33:1364-7.
2. Mallette LE, Gagel RF. 1990 Parathyroid hormone and calcitonin. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism, 1st ed. Richmond: William Byrd Press; 65-70.
3. 3 in chronic renal failure. Kidney Int. 33:1049-58.
4. Baker RI, Abrams SML, Roe CJ, et al. 1989 Early therapy of renal bone disease with calcitriol: a prospective double-blind study. Kidney Int. 36:S140-2.
5. Marie PJ, Lomri A, DeVernejoul MC, et al. 1989 Relationships between histomorphometric features of bone formation aand bone cell characteristics in vitro in renal osteodystrophy. J Clin Endocrinol Metab. 69:1166-73.
6. Recker RR, Kimmei DB, Parfitt MA, Davies KM, Keshawarz N, Flinders S. 1988 Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Mineral Res. 3:133-44.
7. Julian BA, Laskow DA, Dubovsky J, Curtis JJ, Quarles LD. 1991 Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med. 325:544-50.
8. Malluche HH, Meyer W, Sherman D, Massry SG. 1982 Quantitative bone histology in 84 normal American subjects: micromorphometric analysis and evaluation of variance of iliac crest bone. Calcif Tissue Int. 34:449-55.
9. Quarles LD, Davidai GA, Schwab SJ, Bartholomay DW, Lobaugh B. 1988 Oral calcitriol and calcium: efficient therapy for uremic hyperparathyroidism. Kidney Int. 34:840-4.
10. Quarles LD, Lobaugh B. 1989 Equivalency of various methods for estimating osteoid seam width. J Bone Mineral Res. 4:671-7.
11. Parfitt AM, Drezner MK, Glorieux FH, et al. 1987 Bone histomor-phometry: standardization of nomenclature, symbols, and units. J Bone Mineral Res. 2:595-610.
12. Sokal RR, Rohlf FJ. 1981 Biometry: the principles, practice of statistics in biological research, 2nd ed. San Francisco: Freeman; 454.
13. Parisien M, Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. 1990 Bone disease in primary hyperparathyroidism. Endocrinol Metab Clin North Am. 19:19-34.
14. Parisien M, Silverberg SJ, Shane E, et al. 1990 The histomorphom-etry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab. 70:930-8.
15. Gennant HK, Baron JM, Straus FH, Paloyan E, Jowsey J. 1975 Osteosclerosis in primary hyperparathyroidism. Am J Med. 59:10413.
16. Slovik DM, Rosenthal DI, Doppelt SH, et al. 1986 Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1—34) and 1,25-dihydroxyvitamin D. J Bone Mineral Res. 1:377-81.
17. Bordier P, Marie PJ, Arnaud CD. 1975 Evolution of renal osteodystrophy: correlation of bone histomorphometry, serum mineral, and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol. yid-ney Int. 2(Suppl):102-12.
18. Chan Y-L, Furlong TJ, Cornish CJ, Posen S. 1985 Dialysis osteodystrophy. Medicine. 64:296-309.
19. Shen FH, Baylink DJ, Sherrard DJ, Shen L, Maloney NA, Wer-gedal J. 1975 Serum immunoreactive parathyroid hormone and 25-hydroxy vitamin D in patients with uremic bone disease. J Clin Endocrinol Metab. 40:1009-17.
20. Dustan CR, Hills E, Norman AW, et al. 1985 The pathogenesis of renal osteodystrophy: role of vitamin D, aluminum, parathyroid hormone, calcium, and phosphorus. Q J Med. 55:127-44.
21. Andress DL, Endres DB, Maloney MA, Kopp JB, Coburn JW, Sherrard DJ. 1986 Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. J Clin Endocrinol Metab. 63:1163-9.
22. Malluche HH, Faugere M-C, Fanti P, Price PA. 1984 Plasma levels of bone Gla-protein reflect bone formaiion in patients on chronic maintenance dialysis. Kidney Int. 26:869-74.
23. Voigts A, Felsenfeld AJ, Andress DL, Llach F. 1984 Parathyroid hormone and bone histology: response to hypocalcemia in osteitis fibrosa. Kidney Int. 25:445-52.
24. Solal M-EC, Sebert J-L, Boudailliez B, et al. 1991 Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab. 73:516-24.
25. Andress DL, Maloney MA, Endres D, Sherrard DJ. 1986 Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. Kidney Int. 1:391-8.